
Alphavog 0.2 Tablet
Marketer
Proqol Healthcare
Salt Composition
Voglibose (0.2mg)
Overview Alphavog 0.2 Tablet
Glycemia Control 0.2mg tablets are indicated for the management of type 2 diabetes. This medication assists in regulating postprandial hyperglycemia. It's prescribed when dietary modifications and other similar antidiabetic agents prove insufficient in achieving glycemic targets. Administer Glycemia Control 0.2mg immediately prior to meals. Dosage and frequency should be determined by your physician to optimize blood glucose control. Discontinuation should only occur under medical supervision; abrupt cessation may elevate blood sugar, increasing the risk of severe complications including renal impairment and vision loss. This medication forms part of a comprehensive diabetes management plan, encompassing a balanced diet, physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported adverse effects include gastrointestinal upset (flatulence, abdominal pain, anorexia, constipation, diarrhea). Report persistent or troublesome side effects to your doctor. While Glycemia Control 0.2mg alone doesn't typically cause hypoglycemia, concomitant use with other antidiabetic medications (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your physician of any pre-existing liver or kidney conditions before commencing treatment. This medication is contraindicated in individuals with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating women should seek medical advice prior to use. Always disclose all concurrent medications to ensure treatment safety. Limit alcohol consumption, as it may potentiate the risk of hypoglycemia.
Primary Ingredients of Alphavog 0.2 Tablet
No text provided to rephrase.
Uses of Alphavog 0.2 Tablet
Managing type 2 diabetes
Major Benefits of Alphavog 0.2 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Alphavog 0.2 Tablet should be taken on an empty stomach.
Common Side effects of Alphavog 0.2 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Alphavog 0.2 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Alphavog 0.2 Tablet. Always swallow the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
How Alphavog 0.2 Tablet works:
Alphavog 0.2mg tablets are used to manage diabetes. Their mechanism involves blocking intestinal enzymes that digest complex carbohydrates, thus limiting post-meal spikes in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Alphavog 0.2 Tablet.
PregnancySAFE IF PRESCRIBED
The use of Alphavog 0.2 Tablet during pregnancy is generally regarded as safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Alphavog 0.2 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Alphavog 0.2 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Alphavog 0.2 Tablets. Dosage modification for Alphavog 0.2 Tablets may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Alphavog 0.2 Tablets. Dosage modification of Alphavog 0.2 Tablets may be necessary. Physician consultation is advised.
What if you forget to take Alphavog 0.2 Tablet :
Omit any missed Alphavog 0.2 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Alphavog 0.2 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
